We are live on
!
Find out more
Haemonetics
296 hedge funds and large institutions have $4.3B invested in Haemonetics in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 98 increasing their positions, 111 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
281% more call options, than puts
Call options by funds: $8.4M | Put options by funds: $2.21M
3% more capital invested
Capital invested by funds: $4.19B → $4.3B (+$117M)
0.66% less ownership
Funds ownership: 100.61% → 99.95% (-0.66%)
2% less funds holding
Funds holding: 301 → 296 (-5)
11% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 38
12% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 111
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
296
Holders Change
-5
Holders Change %
-1.66%
% of All Funds
4.65%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
34
Increased
98
Reduced
111
Closed
38
Calls
$8.4M
Puts
$2.21M
Net Calls
+$6.2M
Net Calls Change
+$2.93M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$34.4M |
| 2 |
Morgan Stanley
New York
|
+$22.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$18.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.5M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$8.11M |
